Because of the increasing frequency of human infection by nonfastidious, nonfermentative, gram-negative bacteria, the diagnostic laboratory must be able to identify these organisms accurately. Recent reports (3, 7) have appeared documenting the use of antimicrobial susceptibility patterns as an aid in their identification. Based on the results of the susceptibility data presented in this report, it is concluded that the antibiograms of the nonfermentative species examined can be used as an important criterion in their differentiation.
MATERIALS AND METHODS
Most strains examined were recovered from clinical materials submitted to this laboratory and maintained on Trypticase soy agar (BBL) slants at -20 C. The diagnostic criteria for their identification RESULTS AND DISCUSSION Antibacterial spectrum. The results of the antimicrobial tests are recorded in Table 1 . Polymyxin and gentamicin inhibited most strains but had little or no effect against Pseudomonas pseudomallei, P. cepacia, P. diminuta, and Flavobacterium. Streptomycin was effective against Moraxella, Acinetobacter, P. putrefaciens, and P. stutzeri. A broader range of activity was demonstrated by tetracycline and chloramphenicol.
Tetracycline was active against Moraxella and seven Pseudomonas species, whereas chloramphenicol was effective against Moraxella, Flavobacterium, and six Pseudomonas species. Cephalothin was effective against Moraxella and Alcaligenes, but little or no activity was demonstrated against the remainder of the strains. Ampicillin showed marked activity against Moraxella, P. pseudomallei, and P. stutzeri and moderate activity against Alcaligenes and Acinetobacter. Of the broad spectrum antibiotics, neomycin and kanamycin demonstrated the widest range of activity. They were very active against all strains except P. aeruginosa, P. cepacia, P. acidovorans, P. maltophilia, Alcaligenes, and Flavobacteriwn. These observations confirm the conclusion of von Graevenitz and Redys (7) that the broad spectrum antibiotics demonstrate variable activity against nonfermentative bacteria.
Nitrofurazone and nitrofurantoin inhibited Moraxella, P. putrefaciens, and A. odorans, and nitrofurantoin also proved effective against Acinetobacter. This demonstrates that nitrofurantoin has some activity against the nonfermenters although its activity is generally regarded to be limited against members of the Enterobacteriaceae (8) .
Novobiocin and erythromycin were effective against Moraxella, P. diminuta, and Flavobacterium, and penicillin selectively inhibited Moraxella. Similar results with regard to the activity of these antibiotics against nonfermenters have been noted (5, 7) . Of the antimicrobial agents studied, lincomycin displayed the narrowest spectrum.
Species susceptibility. Moraxella was susceptible to all antibacterial agents except lincomy-821 GILARDI APPL. MICROBIOL. Gentamicin. cin, an observation noted by other investigators (6, 7) . This antibiogram differentiates Moraxella from all species except penicillin-susceptible strains of A. iwoffi, which are infrequently encountered. Flavobacterium was susceptible to five antibiotics including novobiocin and erythromycin but failed to respond to kanamycin and polymyxin. As previously noted by Olsen (5) , this unusual sensitivity pattern serves to distinguish Flavobacterium from other species.
Approximately half of the Acinetobacter strains were susceptible to erythromycin, ampicillin, and tetracycline, and most strains were susceptible to streptomycin, nitrofurazone, nalidixic acid, neomycin, kanamycin, polymyxin, and gentamicin. The present results with A. anitratus are in general agreement with the study of Hugh and Reese (4). A. Iwoffi was more susceptible than A. haemolyticus, which was more susceptible than A. anitratus. This feature, also observed by Hejzlar et al. (3) , was particularly evident with penicillin, novobiocin, erythromycin, ampicillin, chloramphenicol, and cephalothin. The susceptibility of A. anitratus and A. haemolyticus to nitrofurazone but not nitrofurantoin or cephalothin is useful in their identification.
All Alcaligenes strains were susceptible to polymyxin and gentamicin, and in addition A. odorans was also susceptible to cephalothin, nitrofurantoin, nitrofurazone, and nalidixic acid. The antibiogram of A. faecalis was similar to the biochemically indistinguishable P. alcaligenes and appears to be of limited value for the identification of Alcaligenes.
As documented elsewhere (6) (7) (8) , the most resistant Pseudomonas species were P. aeruginosa, P. maltophilia, and P. cepacia. P. stutzeri and P. putrefaciens were the most sensitive species. P. aeruginosa responded only to neomycin, polymyxin, and gentamicin. P. maltophilia demonstrated good response to chloramphenicol, nalidixic acid, and polymyxin. P. cepacia was generally susceptible to nalidixic acid and kanamycin and uniformly susceptible to chloramphenicol. Resistance to polymyxin and gentamicin was a unique feature of P. pseudomallei, P. cepacia, and P. diminuta. The simple fluorescent pseudomonads (P. fluorescens, P. putida) were more susceptible than apyocyanogenic strains of P. aeruginosa, which were more susceptible than typically pigmented strains as evidenced by susceptibility to tetracycline, streptomycin, nitrofurazone, and kanamycin. The antibiograms of these nine Pseudomonas species can be used as an aid in their identification, but the susceptibility patterns of P. alcaligenes and P. acidovorans are quite variable and of limited value as a diagnostic aid.
The data presented should be used with caution for several reasons. The susceptibility patterns of these organisms may be altered due to mutation, the excessive use of antimicrobials, and the introduction of new chemotherapeutic agents. Episomal transmission of drug resistance factors, although observed principaUy in the Enterobacteriaceae, may play a role in the nonfermenters. A continuing reassessment of the effectiveness of each agent against the nonfermenters will be necessary through routine susceptibility testing. This scheme is not intended for use as an indicator of drug of choice for therapy and is presented only as a diagnostic guide for the identification of these nonfermenters.
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